Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2570)
All Articles published online
|
Dec 14, 2010 (publication date) through May 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Garcia-Saenz-de-Sicilia M, Sanchez-Avila F, Chavez-Tapia NC, Lopez-Arce G, Garcia-Osogobio S, Ruiz-Cordero R, Tellez-Avila FI. PPIs are not associated with a lower incidence of portal-hypertension-related bleeding in cirrhosis. World J Gastroenterol 2010; 16(46): 5869-5873 [PMID: 21155009 DOI: 10.3748/wjg.v16.i46.5869] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i46/5869.htm |
| Number | Citing Articles |
| 1 |
Tamás Janka, Tamás Tornai, Brigitta Borbély, Dávid Tornai, István Altorjay, Mária Papp, Zsuzsanna Vitális. Deleterious effect of proton pump inhibitors on the disease course of cirrhosis. European Journal of Gastroenterology & Hepatology 2020; 32(2): 257 doi: 10.1097/MEG.0000000000001499
|
| 2 |
Sheref A. Elseidy, Ahmed Sayed, Ahmed K. Awad, Debvarsha Mandal, Mariam Mostafa, Aisha Adigun, Monica Vorla, Zarlakhta Zamani, Amir Iqbal. PPI efficacy in the reduction of variceal bleeding incidence and mortality, a meta-analysis. The Egyptian Journal of Internal Medicine 2022; 34(1) doi: 10.1186/s43162-022-00156-2
|
| 3 |
Malte H. Wehmeyer, Thomas Horvatits, Anika Buchholz, Linda Krause, Sarah Walter, Antonia Zapf, Ansgar W. Lohse, Johannes Kluwe. Stop of proton-pump inhibitor treatment in patients with liver cirrhosis (STOPPIT): study protocol for a prospective, multicentre, controlled, randomized, double-blind trial. Trials 2022; 23(1) doi: 10.1186/s13063-022-06232-w
|
| 4 |
Louise China, Thais Tittanegro, Dominic Crocombe, Ewan Forrest, Yiannis Kallis, Stephen D. Ryder, Gavin Wright, Nick Freemantle, Alastair O'Brien. Investigating potential confounding by indication when considering the association between proton pump inhibitor use, infection, hepatic encephalopathy and mortality in hospitalised decompensated cirrhosis: a post-hoc analysis of the ATTIRE trial. eClinicalMedicine 2023; 58: 101924 doi: 10.1016/j.eclinm.2023.101924
|
| 5 |
Elaine A. G. Lo, Kyle J. Wilby, Mary H. H. Ensom. Use of Proton Pump Inhibitors in the Management of Gastroesophageal Varices. Annals of Pharmacotherapy 2015; 49(2): 207 doi: 10.1177/1060028014559244
|
| 6 |
Zhao-Ni Lin, Yong-Qing Zuo, Peng Hu. Association of Proton Pump Inhibitor Therapy with Hepatic Encephalopathy in Hepatitis B Virus-related Acute-on-Chronic Liver Failure. Hepatitis Monthly 2014; 14(3) doi: 10.5812/hepatmon.16258
|
| 7 |
Jolene F Siple, Jessica M Morey, Tracy E Gutman, Kathy L Weinberg, Peggie D Collins. Proton Pump Inhibitor Use and Association with Spontaneous Bacterial Peritonitis in Patients with Cirrhosis and Ascites. Annals of Pharmacotherapy 2012; 46(10): 1413 doi: 10.1345/aph.1R174
|
| 8 |
Hiroshi Yoshida, Yasuhiro Mamada, Nobuhiko Taniai, Masato Yoshioka, Atsushi Hirakata, Youichi Kawano, Yoshiaki Mizuguchi, Tetsuya Shimizu, Junji Ueda, Eiji Uchida. Risk Factors for Bleeding Esophagogastric Varices. Journal of Nippon Medical School 2013; 80(4): 252 doi: 10.1272/jnms.80.252
|
| 9 |
Xiaoning Chen, Tao Zhou, Ting Zhou, Yueyue Li, Xin Sun, Baoquan Cheng, Ning Zhong, Xuefeng Lu, Yanjing Gao. Effects of proton pump inhibitor on gastroesophageal varices in patients with cirrhosis: A randomized controlled trial from China. Portal Hypertension & Cirrhosis 2023; 2(1): 1 doi: 10.1002/poh2.37
|
| 10 |
Leon Fisher, Alexander Fisher. Acid-Suppressive Therapy and Risk of Infections: Pros and Cons. Clinical Drug Investigation 2017; 37(7): 587 doi: 10.1007/s40261-017-0519-y
|
| 11 |
Lung-Yi Mak, James Fung. Proton pump inhibitors in chronic liver disease: accomplice or bystander?. Hepatology International 2020; 14(3): 299 doi: 10.1007/s12072-020-10033-1
|
| 12 |
Mihajlo Gjeorgjievski, Mitchell S Cappell. Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy. World Journal of Hepatology 2016; 8(4): 231-262 doi: 10.4254/wjh.v8.i4.231
|
| 13 |
H. L. Cole, S. Pennycook, P. C. Hayes. The impact of proton pump inhibitor therapy on patients with liver disease. Alimentary Pharmacology & Therapeutics 2016; 44(11-12): 1213 doi: 10.1111/apt.13827
|
| 14 |
L. Veremme, A. Baudouin, A. Janoly-Dumenil, B. Charpiat. Thésaurus d’interventions pharmaceutiques associées aux prescriptions injustifiées d’inhibiteurs de la pompe à protons. Annales Pharmaceutiques Françaises 2023; 81(3): 552 doi: 10.1016/j.pharma.2022.11.006
|
| 15 |
D. K. Li, P. Yan, A‐B. Abou‐Samra, R. T. Chung, A. A. Butt. Proton pump inhibitors are associated with accelerated development of cirrhosis, hepatic decompensation and hepatocellular carcinoma in noncirrhotic patients with chronic hepatitis C infection: results from ERCHIVES. Alimentary Pharmacology & Therapeutics 2018; 47(2): 246 doi: 10.1111/apt.14391
|
| 16 |
Imran Khawaja, Muhammad Babar, Shakeel Ahmad Awan, Asif J Shaikh, Adnan A Abbasi. Effectiveness of Proton Pump Inhibitor Therapy in the Prevention of Bleeding After Prophylactic Endoscopic Variceal Band Ligation. Cureus 2023; doi: 10.7759/cureus.33932
|
| 17 |
Tsung-Hsing Hung, Hsing-Feng Lee, Chih-Wei Tseng, Chih-Chun Tsai, Chen-Chi Tsai. Effect of proton pump inhibitors in hospitalization on mortality of patients with hepatic encephalopathy and cirrhosis but no active gastrointestinal bleeding. Clinics and Research in Hepatology and Gastroenterology 2018; 42(4): 353 doi: 10.1016/j.clinre.2017.11.011
|
| 18 |
Yudai Koya, Michihiko Shibata, Tatsuyuki Watanabe, Shinsuke Kumei, Koichiro Miyagawa, Shinji Oe, Yuichi Honma, Keiichiro Kume, Ichiro Yoshikawa, Masaru Harada. Influence of gastroesophageal flap valve on esophageal variceal bleeding in patients with liver cirrhosis. Digestive Endoscopy 2021; 33(1): 100 doi: 10.1111/den.13685
|
| 19 |
Mauricio Garcia-Saenz-de-Sicilia, Lolwa Al-Obaid, Dempsey L. Hughes, Andrés Duarte-Rojo. Mastering Core Recommendations during HEPAtology ROUNDS in Patients with Advanced Chronic Liver Disease. Seminars in Liver Disease 2022; 42(03): 341 doi: 10.1055/a-1886-5909
|
| 20 |
Sameh A. Lashen, Mohammed M. Shamseya, Ayman M. Shamseya, Fahmy H. Hablass. Efficacy of Vonoprazan vs. Pantoprazole or Non-acid Suppression in Prevention of Post-variceal Ligation Ulcer Bleeding in Portal Hypertension: A Multi-arm Randomized Controlled Trial. Journal of Clinical and Experimental Hepatology 2023; 13(6): 962 doi: 10.1016/j.jceh.2023.05.008
|
| 21 |
Ummi Maimunah, Andreas Agung Kurniawan, Andrio Palayukan. Adverse Effects of Long-term Proton Pump Inhibitors in Chronic Liver Disease Patients – A Preliminary Article Review. Review of Clinical Pharmacology and Pharmacokinetics - International Edition 2024; 38(1): 87 doi: 10.61873/WWAY6273
|
| 22 |
Darrick K. Li, Raymond T. Chung. Use of proton pump inhibitors in chronic liver diseases. Clinical Liver Disease 2017; 10(6): 148 doi: 10.1002/cld.678
|
| 23 |
Amit Kumar Dutta, Abhinav Jain, Vaneet Jearth, Ramit Mahajan, Manas Kumar Panigrahi, Vishal Sharma, Mahesh Kumar Goenka, Rakesh Kochhar, Govind Makharia, Duvvur Nageshwar Reddy, Richard Kirubakaran, Vineet Ahuja, Neha Berry, Naresh Bhat, Usha Dutta, Uday Chand Ghoshal, Ajay Jain, Umesh Jalihal, V. Jayanthi, Ajay Kumar, Sandeep Nijhawan, Ujjal Poddar, G. N. Ramesh, Shivram P Singh, Showkat Zargar, Shobna Bhatia. Guidelines on optimizing the use of proton pump inhibitors: PPI stewardship. Indian Journal of Gastroenterology 2023; 42(5): 601 doi: 10.1007/s12664-023-01428-7
|
| 24 |
Hassan Ghoz, Payal Patel, Fernando Stancampiano, Sheetal Patel, Erin A. Fox, Mohammad B. Yousaf, Mohamed Omer, Michael G. Heckman, Matthew R. Spiegel, William C. Palmer. Proton-pump-inhibitor use associated with lower short-term rebleeding and mortality in patients receiving esophageal variceal band ligation: a retrospective cohort study. European Journal of Gastroenterology & Hepatology 2020; 32(12): 1571 doi: 10.1097/MEG.0000000000001905
|
| 25 |
Antonio Picardi, Umberto Vespasiani-Gentilucci. Proton pump inhibitor prescription abuse and sepsis in cirrhosis. World Journal of Gastrointestinal Pharmacology and Therapeutics 2016; 7(1): 1-4 doi: 10.4292/wjgpt.v7.i1.1
|